December 28, 2024Open Access

Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder

Key Points

Key points are not available for this paper at this time.

Abstract

In a population of individuals diagnosed with DSRD, abnormalities in serum cytokine levels, neuroimaging findings, and CSF analysis emerged as indicators of disease severity and responsiveness to immunotherapy.

AIに質問

Bookmark

View Full Paper

Cite This Study

Santoro et al. (Sat,) studied this question.

synapsesocial.com/papers/69d955aa7fca1f84ab684bc7 https://doi.org/https://doi.org/10.1038/s41598-024-81819-8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intravenous immunoglobulin in neurology—mode of action and clinical efficacy2015 · 305 citations
2Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States2015 · 289 citations
3Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis2020 · 4 citations
4Medical conditions of children and young people with Down syndrome2021 · 24 citations
5Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications1998 · 159 citations

AIに質問

Bookmark

View Full Paper